Antimetabolite Immunosuppressant class drugs

2 results
  • mycophenolic acid

    (mycophenilic acid)
    Archis Pharma LLC
    Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in kidney transplant patients, both adult and pediatric (5 years and older), in combination with cyclosporine and corticosteroids. Use interchangeably with mycophenolate mofetil is not recommended without physician supervision.
  • myfortic

    (mycophenolic acid)
    Novartis Pharmaceuticals Corporation
    Myfortic (mycophenolic acid) is indicated for the prophylaxis of organ rejection in adult and pediatric kidney transplant patients (5 years and older, at least 6 months post-transplant), to be used alongside cyclosporine and corticosteroids. Use caution as it should not be interchangeable with mycophenolate mofetil without physician supervision.